1. Home
  2. EVO vs LNN Comparison

EVO vs LNN Comparison

Compare EVO & LNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.50

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Lindsay Corporation

LNN

Lindsay Corporation

HOLD

Current Price

$136.41

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
LNN
Founded
1993
1954
Country
Germany
United States
Employees
4766
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
EVO
LNN
Price
$3.50
$136.41
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$7.00
$128.00
AVG Volume (30 Days)
138.6K
60.3K
Earning Date
01-01-0001
04-09-2026
Dividend Yield
N/A
1.09%
EPS Growth
N/A
12.81
EPS
N/A
1.54
Revenue
N/A
$676,368,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.13
$5.91
P/E Ratio
N/A
$88.43
Revenue Growth
N/A
11.41
52 Week Low
$2.84
$106.10
52 Week High
$4.80
$149.56

Technical Indicators

Market Signals
Indicator
EVO
LNN
Relative Strength Index (RSI) 49.94 62.73
Support Level $3.52 $131.71
Resistance Level $3.67 $140.31
Average True Range (ATR) 0.09 4.61
MACD -0.02 0.07
Stochastic Oscillator 36.36 41.62

Price Performance

Historical Comparison
EVO
LNN

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About LNN Lindsay Corporation

Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.

Share on Social Networks: